Home | Health News | Themes | Search | Blog | Testimonials | Blood Bank | About Us
 
   
   
   
   
   
   
   
 

 
   
ALFOO  ALFUSIN  FUAL  XELFLO 
Frequently Asked Questions(FAQS)
 
 
Mechanism of Action
Alfuzosin is a quinazoline-derivative which exhibits selectivity for α1-adrenergic receptors in the lower urinary tract. Blockade of these adrenoreceptors causes relaxation of smooth muscle in the bladder neck and prostate, resulting in improvement in urine flow and a reduction in symptoms of benign prostatic hyperplasia.



Indication & Dosage
 
 
Oral
BENIGN PROSTATIC HYPERPLASIA
Adult:

2.5 mg tid. Max dose: 10 mg daily.
 

Elderly: Initially, 2.5 mg bid

  
AdministrationShould be taken with food.
  
PrecautionsElderly; hypertension; coronary insufficiency; angina (discontinue); renal or hepatic impairment. Monitor BP regularly. May affect ability to drive or operate machinery.
  
Adverse Drug Reactions Drowsiness, postural hypotension, syncope, asthenia, depression, headache, dry mouth, GI disturbances, edema, blurred vision, rhinitis, erectile disorders, tachycardia, palpitation, hypersensitivity reactions; flushes; chest pain; dizziness; lack of energy.
  
InteractionsCYP3A4 inhibitors e.g. azole antifungals, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, telithromycin, and verapamil may increase the levels of alfuzosin. Reduced serum levels when used with CYP3A4 inducers e.g. aminoglutethimide, carbamazepine, nafcillin, nevirapine, phenobarbital, phenytoin and rifamycins.
  
   
 

 

SocialTwist Tell-a-Friend
 
 
Home  |   Privacy Policy   |   News Lettter   |   Site Map   |  Disclaimer  |  About Us
   copyright@totalhealthneeds.com   Webmaster:- o3sa.co.in